drugset / Trial / NCT01646619

Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy

NCT01646619

Phase 3 Unknown 300 enrolled Sajjad Rahman
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to assess whether the addition of a drug such as Magnesium sulphate while providing therapeutic hypothermia (or cooling) to babies who are asphyxiated at birth provides additional benefit to the babies' survival and outcome compared to cooling alone.

Timeline

Start
2012-05
Primary completion
2013-12
Completion
2014-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 250 mg/kg Intravenous